Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial - Nauck, M A; Del Prato, S; Meier, J J (Diabetes Care, 2011)
et al.